Loading provider…
Loading provider…
Infectious Disease Physician in Birmingham, AL
NPI: 1043247265Primary Employer
University of Alabama Health Services Foundation, PC.
uabmedicine.org
HQ Phone
Get Edward's Phone Numberphone_androidMobile
Get Edward's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAL State Medical License
AL State Medical License
1992 - 2024
MD State Medical License
1985 - 1992

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Infectious Disease
Weill Cornell Medicine
weill.cornell.edu
Medical School
Until 1976
University of Washington
Fellowship • Infectious Disease
1980 - 1983
Residency • Internal Medicine
1976 - 1980
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 14 | 49 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 12 | 12 |
| 3 | 99238Hospital discharge day management, 30 minutes or less | 12 | 12 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 11 | 35 |
Authors: Crosby, R, DiClemente, R J, Wingood, G M, Sionean, C, Cobb, B K, Harrington, K, Davies, S, Hook, E W, Oh, M K
Journal: J Adolesc Health
Temporal trends in gonococcal antibiotic resistance in Baltimore.
Authors: Reichart, C A, Neumann, T, Foreman, P, Zenilman, J M, Hook, E W
Journal: Sex Transm Dis
Motorcycle taxi drivers and sexually transmitted infections in a Peruvian Amazon City.
Authors: Paris, M, Gotuzzo, E, Goyzueta, G, Aramburu, J, Caceres, C F, Crawford, D, Castellano, T, Vermund, S H, Hook, E W
Journal: Sex Transm Dis
Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Intervention / Treatment: DRUG: Benzathine Penicillin
Lead Sponsor: Melinta Therapeutics, Inc.
Intervention / Treatment: DRUG: solithromycin, DRUG: Solithromycin (CEM-101)
Lead Sponsor: University of Alabama at Birmingham
Collaborators: GlaxoSmithKline
Intervention / Treatment: DRUG: Placebo, DRUG: Valacyclovir